Vicky Wu

461 total citations
26 papers, 234 citations indexed

About

Vicky Wu is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vicky Wu has authored 26 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 5 papers in Otorhinolaryngology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vicky Wu's work include CAR-T cell therapy research (11 papers), Head and Neck Cancer Studies (5 papers) and Biosimilars and Bioanalytical Methods (3 papers). Vicky Wu is often cited by papers focused on CAR-T cell therapy research (11 papers), Head and Neck Cancer Studies (5 papers) and Biosimilars and Bioanalytical Methods (3 papers). Vicky Wu collaborates with scholars based in United States, Canada and Australia. Vicky Wu's co-authors include Jenna Voutsinas, David G. Maloney, Stephanie J. Lee, Ana Cordeiro, Erin Mullane, Merav Bar, Jesse R. Fann, Bronwen E. Shaw, Evandro D. Bezerra and Cameron J. Turtle and has published in prestigious journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment and Journal of Thoracic Oncology.

In The Last Decade

Vicky Wu

24 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicky Wu United States 7 170 47 41 35 28 26 234
Lamis Eldjerou United States 10 178 1.0× 38 0.8× 34 0.8× 55 1.6× 20 0.7× 22 260
Erin Mullane United States 7 270 1.6× 65 1.4× 32 0.8× 57 1.6× 15 0.5× 15 298
Ana Cordeiro Brazil 5 332 2.0× 68 1.4× 51 1.2× 47 1.3× 16 0.6× 21 400
Carolyn Mulroney United States 8 78 0.5× 27 0.6× 34 0.8× 26 0.7× 33 1.2× 29 210
Emma Grigor Canada 7 143 0.8× 37 0.8× 24 0.6× 37 1.1× 4 0.1× 21 265
Bryan Do United States 6 187 1.1× 45 1.0× 17 0.4× 53 1.5× 5 0.2× 7 288
Ira L. Kraft United States 9 130 0.8× 49 1.0× 14 0.3× 43 1.2× 14 0.5× 19 295
Zitong Chen China 4 216 1.3× 48 1.0× 16 0.4× 58 1.7× 6 0.2× 13 290
Christopher J. Forlenza United States 8 182 1.1× 14 0.3× 33 0.8× 143 4.1× 19 0.7× 28 300

Countries citing papers authored by Vicky Wu

Since Specialization
Citations

This map shows the geographic impact of Vicky Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky Wu more than expected).

Fields of papers citing papers by Vicky Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky Wu. The network helps show where Vicky Wu may publish in the future.

Co-authorship network of co-authors of Vicky Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky Wu. A scholar is included among the top collaborators of Vicky Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky Wu. Vicky Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fromm, Jonathan R., Min Fang, Brian G. Till, et al.. (2023). Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.. Journal of Clinical Oncology. 41(16_suppl). 7561–7561. 1 indexed citations
2.
Rodriguez, Cristina P., Vicky Wu, Jenna Voutsinas, et al.. (2023). Dual PD1 and CTLA4 immune checkpoint blockade and hypofractionated radiation in patients with salivary gland cancers.. Journal of Clinical Oncology. 41(16_suppl). 6011–6011. 1 indexed citations
3.
Duenas, Devan M., Jenna Voutsinas, Vicky Wu, et al.. (2023). Pediatric oncologist referral practices for CAR T-cell therapy: A mixed methods study.. Journal of Clinical Oncology. 41(16_suppl). 10026–10026. 1 indexed citations
4.
Pinto, Navin, Catherine M. Albert, Mallory Taylor, et al.. (2023). Effect of bispecific B7H3 x CD19 CAR T cells on host CD19 expression and CAR T cell engraftment.. Journal of Clinical Oncology. 41(16_suppl). 10043–10043. 2 indexed citations
5.
Cooper, Todd M., Vicky Wu, Ashley Wilson, et al.. (2022). Pediatric and young adult leukemia adoptive therapy (PLAT)-08: A phase 1 study of SC-DARIC33 in pediatric and young adults with relapsed or refractory CD33+ AML.. Journal of Clinical Oncology. 40(16_suppl). TPS7078–TPS7078. 6 indexed citations
6.
Pinto, Navin, Catherine M. Albert, Mallory Taylor, et al.. (2022). STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed/refractory solid tumors.. Journal of Clinical Oncology. 40(16_suppl). 10011–10011. 23 indexed citations
7.
Voutsinas, Jenna, Vicky Wu, Diane Tseng, et al.. (2022). Socioeconomic factors and outcomes among patients with recurrent/metastatic head and neck cancer receiving immunotherapy.. Journal of Clinical Oncology. 40(28_suppl). 153–153. 1 indexed citations
8.
Chalasani, Pavani, Vicky Wu, Isaac Jenkins, et al.. (2021). Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer. Breast Cancer Research and Treatment. 188(1). 91–99. 3 indexed citations
9.
Voutsinas, Jenna, Vicky Wu, Jay J. Liao, et al.. (2021). Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution. Oral Oncology. 123. 105626–105626.
10.
Wu, Vicky, et al.. (2021). Effect of Turmeric Concentrations on the Rate of Growth of Oral Bacteria—An In-Vitro Study. Dentistry Journal. 9(3). 26–26. 2 indexed citations
11.
Kinahan, Paul E., et al.. (2020). IA07 Plasma Proteomic, Glycomic, and Autoantibody Biomarkers for Lung Cancer Early Detection. Journal of Thoracic Oncology. 15(2). S3–S3. 1 indexed citations
12.
Gardner, Rebecca, Colleen Annesley, Ashley Wilson, et al.. (2020). Efficacy of SCRI-CAR19x22 T cell product in B-ALL and persistence of anti-CD22 activity.. Journal of Clinical Oncology. 38(15_suppl). 3035–3035. 10 indexed citations
13.
Mullane, Erin, Ana Cordeiro, Evandro D. Bezerra, et al.. (2019). Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy. Biology of Blood and Marrow Transplantation. 26(1). 34–43. 108 indexed citations
14.
Concannon, Kyle, et al.. (2019). Outcomes among patients with a history of substance abuse in non-small cell lung cancer: A county hospital experience.. Journal of Clinical Oncology. 37(15_suppl). e20031–e20031. 1 indexed citations
15.
Khera, Nandita, Betty K. Hamilton, Joseph A. Pidala, et al.. (2018). Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America. Biology of Blood and Marrow Transplantation. 25(3). 599–605. 28 indexed citations
16.
Hay, Kevin A., Jordan Gauthier, Alexandre V. Hirayama, et al.. (2018). Factors impacting disease-free survival in adult B cell B-ALL patients achieving MRD-negative CR after CD19 CAR-T cells.. Journal of Clinical Oncology. 36(15_suppl). 7005–7005. 2 indexed citations
17.
Khera, Nandita, Betty K. Hamilton, William A. Wood, et al.. (2018). Employment, Insurance and Financial Experiences of Patients with Chronic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 24(3). S30–S31. 1 indexed citations
18.
Gauthier, Jordan, Alexandre V. Hirayama, Kevin A. Hay, et al.. (2018). Factors associated with duration of response after CD19-specific CAR-T cell therapy for refractory/relapsed B-cell non-Hodgkin lymphoma.. Journal of Clinical Oncology. 36(15_suppl). 7567–7567. 6 indexed citations
19.
Peterson, Lanell M., Vicky Wu, Isaac Jenkins, et al.. (2018). 18F-Fluoroestradiol (FES) and 18F-Fluorodeoxyglucose (FDG) PET imaging in lobular breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 1063–1063. 1 indexed citations
20.
Bardzell, Shaowen, et al.. (2007). Transmedial interactions and digital games. 307–308. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lamis Eldjerou Breakdown of academic impact, for papers by Erin Mullane Breakdown of academic impact, for papers by Ana Cordeiro Breakdown of academic impact, for papers by Carolyn Mulroney Breakdown of academic impact, for papers by Emma Grigor Breakdown of academic impact, for papers by Bryan Do Breakdown of academic impact, for papers by Ira L. Kraft Breakdown of academic impact, for papers by Zitong Chen Breakdown of academic impact, for papers by Christopher J. Forlenza
Rankless by CCL
2026